Envista NVST · NYSE
$23.51 -4.47% (-$1.10)
Summary
61 / 100 · Bulios Score
What speaks for it
- It earns 2,382,560 USD a year on every 100 USD of invested capital.
- It bought back its own shares for $166.6M in the last fiscal year, 4.2% of its market value.
What to watch
- Earnings per share fell by 41% a year over the last 3 years.
- You pay 41.6 USD for 1 USD of yearly profit, a lot for its sector.
- Out of every 100 USD of revenue, only 3.3 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 41.6 USD for 1 USD of yearly profit. Over the last five years it was 42.1 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.1% a year over 5 years. Over the last 3 years it grew by 1.9% a year. For the next fiscal year analysts expect revenue to grow by 5.8%. Earnings per share fell by 41% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 45 USD
- Research and development 4.2 USD
- Sales and administration 41 USD
- Taxes and other 6.6 USD
- Net profit 3.3 USD
Net profit, industry median (Medical - Instruments & Supplies) 8.4 USD
Out of every 100 USD of revenue, 3.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 11
- Sell 1
Today's price within the analysts' price targets
The average target of $29.11 is 24% above today's price. 40% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Specialty Products and Technologies 64%
- Equipment and Consumables 36%
By region
- UNITED STATES 47%
- All Other Countries 46%
- CHINA 7.1%
Specialty Products and Technologies brings in 64% of revenue.
Segments in detail